Набор по приглашению NCT06828614

Barriers to Therapeutic Exercise in Breast Cancer Patients Before, During, and After Chemotherapy

— Наблюдательное Breast Cancer

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают: В протоколе указаны: Chemotherapy.
Кому может быть актуально: Состояния в реестре: Breast Cancer. Базовые параметры: 18 лет — 65 лет · Женщины.
Что важно проверить: Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится: Испания
Следующий шаг: Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Официальное название

Evaluation of the Barriers to Therapeutic Exercise Perceived by People With Breast Cancer Who Are Undergoing Chemotherapy in an Observational Study

Обзор

Cancer is one of the leading causes of mortality. First-choice cancer treatments, such as chemotherapy, have increased the survival of people with cancer, although they are not without adverse effects such as cardiotoxicity, fatigue, nausea, mental health problems or musculoskeletal disorders. Therapeutic exercise is a safe and effective intervention that has shown positive results in the oncology population when implemented as an adjuvant to chemotherapy, during or after chemotherapy. Exercise improves cardiorespiratory capacity, fatigue, strength, anxiety, depressive symptoms and quality of life, among others, in cancer patients. In the implementation of therapeutic exercise in the oncologic population undergoing chemotherapy treatment, it is necessary to take into account possible barriers related to the perception of therapeutic exercise, as well as the side effects derived from chemotherapy. It is necessary to know the barriers to the implementation of exercise in order to address them and favor patients' adherence to exercise programs. The objective is to identify the barriers (physical, contextual and emotional) that may influence people with breast cancer who are in the pre-, concurrent or post-treatment phase, respectively, of chemotherapy treatment for the implementation of therapeutic exercise. The study participants (n=111) will be distributed in the study groups according to the moment of chemotherapy treatment they are in (1: pre-chemotherapy, 2: during chemotherapy, 3: post-chemotherapy).

Вмешательства

Препарат Chemotherapy
The present approved ethics committee includes the conduct of two studies. In the first one, a cross-sectional study, breast cancer patients will be distributed in the study groups according to the moment of their chemotherapy treatment (group 1: pre-chemotherapy, group 2: during chemotherapy, group 3: post-chemotherapy). Each patient will undergo a single evaluation session, which will include the variables detailed in the following section. In the second, a longitudinal study, patients from t

Первичные конечные точки

Cancer-related fatigue [Срок оценки: Day 1]

Вторичные конечные точки (12)

Body composition [Срок оценки: Day 1]
Muscle strength [Срок оценки: Day 1]
Upper limb function [Срок оценки: Day 1.]
Functional capacity [Срок оценки: Day 1.]
Physical activity [Срок оценки: Day 1]
Self-efficacy for physical activity [Срок оценки: Day 1]
Leisure time physical activity [Срок оценки: Day 1]
Physical fitness [Срок оценки: Day 1]
Quality of life (EORT QLQ-BR23) [Срок оценки: Day 1]
Mood [Срок оценки: Day 1]
Kinesiophobia [Срок оценки: Day 1]
Anxiety and depression [Срок оценки: Day 1]

Критерии участия

Критерии включения

Women over 18 years of age with a diagnosis of breast cancer, stages I to IIIa.
The sample will be distributed to three groups according to the time of treatment in which the patients are: a) patients diagnosed with breast cancer scheduled to start chemotherapy treatment, b) patients who at the time of the study are receiving chemotherapy and c) patients who have completed chemotherapy treatment 6 months ago or more.